FRA:CVS - Deutsche Boerse Ag - US1266501006 - Common Stock - Currency: EUR
CVS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 25 industry peers in the Health Care Providers & Services industry. CVS has a bad profitability rating. Also its financial health evaluation is rather negative. CVS has a valuation in line with the averages, but it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 1.75% | ||
ROE | 5.86% | ||
ROIC | 4.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 2.65% | ||
PM (TTM) | 1.17% | ||
GM | 13.82% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.78 | ||
Debt/FCF | 13.91 | ||
Altman-Z | 2.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.8 | ||
Quick Ratio | 0.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.09 | ||
Fwd PE | 9.91 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 18.61 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.99% |
FRA:CVS (8/18/2025, 7:00:00 PM)
60.24
+1.77 (+3.03%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.99% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.09 | ||
Fwd PE | 9.91 | ||
P/S | 0.23 | ||
P/FCF | 18.61 | ||
P/OCF | 11.75 | ||
P/B | 1.15 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 1.75% | ||
ROE | 5.86% | ||
ROCE | 6.23% | ||
ROIC | 4.57% | ||
ROICexc | 5% | ||
ROICexgc | 21.47% | ||
OM | 2.65% | ||
PM (TTM) | 1.17% | ||
GM | 13.82% | ||
FCFM | 1.24% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.78 | ||
Debt/FCF | 13.91 | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | 0.72% | ||
Interest Coverage | -3.41 | ||
Cash Conversion | N/A | ||
Profit Quality | 105.5% | ||
Current Ratio | 0.8 | ||
Quick Ratio | 0.62 | ||
Altman-Z | 2.18 |